Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Apr 1;13:2725–2738. doi: 10.2147/OTT.S236359

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2020 Gao et al.

This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).

PMC Copyright notice

miR-122-5p reversed FSTL3-induced NSCLC progression. (A) qRT-PCR showed that the expression of FSTL3 decreased in A549 cells overexpressing miR-122-5p. (B) EdU assay showed that miR-122-5p reversed the promoting effect of FSTL3 on cell proliferation. (C) Transfection of miR-122-5p inhibited the promotion of cell migration induced by FSTL3 overexpression. (D) qRT-PCR showed that the expression of FSTL3 was increased in H1299 cells with inhibited miR-122-5p. (E) EdU assay showed that inhibition of miR-122-5p reversed the inhibitory effect of FSTL3 knockdown on cell proliferation. (F) Inhibition of miR-122-5p reversed the inhibitory effect of FSTL3 knockdown on cell migration. ***P<0.001.